Newly Emerging Immunotherapy for Pancreatic Cancer Treatment

Conditions: Pancreatic Cancer Interventions: Drug: JS001; Drug: JS004; Drug: JS007; Drug: JS015; Drug: Irinotecan Liposome Injection; Drug: 5-Fluorouracil (5-FU); Drug: Leucovorin (LV); Drug: Nab paclitaxel; Drug: Gemcitabine Sponsors: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials